2m 2m 2m 2m 2m 2m 2m
HARVARD BIO (HBIO)
NASDAQ
$8.41+$0.06 (+0.78%)
Price as of Oct 22, 2026 7:50 PM EDT- $38.6MMarket Cap
- 106.54%1-Year Change
- Medical Instruments & SuppliesIndustry
HARVARD BIO (HBIO)
$8.41+$0.06 (+0.78%)
HBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.34 | ||
Change | -$0.15 (-1.77%) | ||
Open | $8.38 | ||
High | $8.45 | ||
Low | $8.33 | ||
Previous Close | $8.49 | ||
Volume | 4,432 | ||
30-Day Average Volume | 16,470 | ||
1-Week Change | 0.36% | ||
1-Month Change | 5.30% | ||
1-Year Change | 106.54% | ||
3-Year Change | -80.51% | ||
5-Year Change | -88.02% | ||
Fundamentals | |||
Shares Outstanding | 4.6M | ||
Total Assets | $76.3M | ||
Market Cap | $38.6M | ||
Enterprise Value | $68.8M | ||
Period: QTR TTM FY | |||
Revenue | $22.7M | ||
Net Income | -$2.9M | ||
Free Cash Flow | -$363,000.00 | ||
EBIT | -$1.1M | ||
EBITDA | -$636,000.00 | ||
Net Working Capital | $21.7M | ||
EPS | -$0.64 | ||
Enterprise Value/EBITDA | -108 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 5 | ||
P/E | -13 | ||
PEG | -1 | ||
Price/Free Cash Flow | -106 | ||
Price/Operating Cash Flow | 119 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/16/2026 | ||
Earnings & Revenue